Literature DB >> 27465259

The nuts and bolts of the endogenous spliceosome.

Ruth Sperling1.   

Abstract

The complex life of pre-mRNA from transcription to the production of mRNA that can be exported from the nucleus to the cytoplasm to encode for proteins entails intricate coordination and regulation of a network of processing events. Coordination is required between transcription and splicing and between several processing events including 5' and 3' end processing, splicing, alternative splicing and editing that are major contributors to the diversity of the human proteome, and occur within a huge and dynamic macromolecular machine-the endogenous spliceosome. Detailed mechanistic insight of the splicing reaction was gained from studies of the in vitro spliceosome assembled on a single intron. Because most pre-mRNAs are multiintronic that undergo alternative splicing, the in vivo splicing machine requires additional elements to those of the in vitro machine, to account for all these diverse functions. Information about the endogenous spliceosome is emerging from imaging studies in intact and live cells that support the cotranscriptional commitment to splicing model and provide information about splicing kinetics in vivo. Another source comes from studies of the in vivo assembled spliceosome, isolated from cell nuclei under native conditions-the supraspliceosome-that individually package pre-mRNA transcripts of different sizes and number of introns into complexes of a unique structure, indicating their universal nature. Recent years have portrayed new players affecting alternative splicing and novel connections between splicing, transcription and chromatin. The challenge ahead is to elucidate the structure and function of the endogenous spliceosome and decipher the regulation and coordination of its network of processing activities. WIREs RNA 2017, 8:e1377. doi: 10.1002/wrna.1377 For further resources related to this article, please visit the WIREs website.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27465259     DOI: 10.1002/wrna.1377

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  17 in total

1.  Daedal Facets of Splice Modulator Optimization.

Authors:  Warren C Chan; Brian León; Kelsey A Krug; Ashay Patel; James J La Clair; Michael D Burkart
Journal:  ACS Med Chem Lett       Date:  2018-10-29       Impact factor: 4.345

Review 2.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

Review 3.  Structural studies of the endogenous spliceosome - The supraspliceosome.

Authors:  Joseph Sperling; Ruth Sperling
Journal:  Methods       Date:  2017-04-13       Impact factor: 3.608

4.  Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53.

Authors:  Marie-Claude Beauchamp; Anissa Djedid; Eric Bareke; Fjodor Merkuri; Rachel Aber; Annie S Tam; Matthew A Lines; Kym M Boycott; Peter C Stirling; Jennifer L Fish; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

Review 5.  Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.

Authors:  L M Gallego-Paez; M C Bordone; A C Leote; N Saraiva-Agostinho; M Ascensão-Ferreira; N L Barbosa-Morais
Journal:  Hum Genet       Date:  2017-04-03       Impact factor: 4.132

6.  Changes in Alternative Splicing as Pharmacodynamic Markers for Sudemycin D6.

Authors:  Morgan Thurman; Jacob van Doorn; Barbara Danzer; Thomas R Webb; Stefan Stamm
Journal:  Biomark Insights       Date:  2017-09-12

7.  Herboxidiene triggers splicing repression and abiotic stress responses in plants.

Authors:  Sahar AlShareef; Yu Ling; Haroon Butt; Kiruthiga G Mariappan; Moussa Benhamed; Magdy M Mahfouz
Journal:  BMC Genomics       Date:  2017-03-27       Impact factor: 3.969

8.  Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.

Authors:  Lydia A Hepburn; Angela McHugh; Kenneth Fernandes; Garry Boag; Charlotte M Proby; Irene M Leigh; Mark K Saville
Journal:  Oncotarget       Date:  2018-05-01

9.  Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.

Authors:  Erin J Vanzyl; Kayleigh R C Rick; Alex B Blackmore; Erin M MacFarlane; Bruce C McKay
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

10.  Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.

Authors:  Manaswini Sivaramakrishnan; Kathleen D McCarthy; Sébastien Campagne; Sylwia Huber; Sonja Meier; Angélique Augustin; Tobias Heckel; Hélène Meistermann; Melanie N Hug; Pascale Birrer; Ahmed Moursy; Sarah Khawaja; Roland Schmucki; Nikos Berntenis; Nicolas Giroud; Sabrina Golling; Manuel Tzouros; Balazs Banfai; Gonzalo Duran-Pacheco; Jens Lamerz; Ying Hsiu Liu; Thomas Luebbers; Hasane Ratni; Martin Ebeling; Antoine Cléry; Sergey Paushkin; Adrian R Krainer; Frédéric H-T Allain; Friedrich Metzger
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.